MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Drug-Eluting Stents Target Restenosis
An innovative technology continues to evolve.
By TIMOTHY M. SULLIVAN, MD
TEVAR With Surgical Brachiocephalic Debranching
Facilitating safe repair of complex pathology.
By Timothy M. Sullivan, MD, FACS, FSVM, FACC
Carotid Endarterectomy: The Eversion Technique
A look at the eversion approach to CEA, including technical tips, available data, and how to decide when this might be the best option.
By Timothy M. Sullivan, MD, FACS, FSVS, FSVM, FACC
FDA Approves Veryan Medical's BioMimics 3D Vascular Stent System
October 4, 2018—Veryan Medical Ltd. announced that it has received FDA premarket approval for its BioMimics three-dimensional (3D) vascular stent system for the treatment of symptomatic de novo or restenotic lesions in the native superficial femoral artery and/or proximal popliteal artery.
Exploring Vascular Pearls and Pitfalls
By Bruce H. Gray, DO, FSCAI, MSVM
Interim Results From the VIVA I: Xcell Trial
Bare-nitinol stenting of tibial arteries and wound-healing assessment in critical limb ischemia patients.
By Krishna Rocha-Singh, MD, FACC, on behalf of VIVA Physicians, Inc.
